Greenfield Seitz Capital Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Greenfield Seitz Capital Management, LLC
- $310 Billion
- Q3 2025
A detailed history of Greenfield Seitz Capital Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Greenfield Seitz Capital Management, LLC holds 3,260 shares of REGN stock, worth $2.26 Million. This represents 0.59% of its overall portfolio holdings.
Number of Shares
3,260
Previous 3,214
1.43%
Holding current value
$2.26 Million
Previous $1.69 Billion
8.63%
% of portfolio
0.59%
Previous 0.6%
Shares
8 transactions
Others Institutions Holding REGN
# of Institutions
1,466Shares Held
86.4MCall Options Held
2.42MPut Options Held
1.64M-
Vanguard Group Inc Valley Forge, PA9.05MShares$6.27 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.86 Billion0.2% of portfolio
-
State Street Corp Boston, MA4.69MShares$3.25 Billion0.09% of portfolio
-
Dodge & Cox San Francisco, CA4.55MShares$3.16 Billion1.47% of portfolio
-
Jpmorgan Chase & CO New York, NY4.07MShares$2.82 Billion0.15% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $74.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...